Corporate News 

RHÖN-KLINIKUM AG: Interim Report for the First Quarter of 2017: New Board of Management tackles main tasks - focus on raising profitability and putting campus concept into practice - outlook for 2017 

- 212,187 patients treated

- Revenues amount to EUR 300.1 million

- EBITDA stands at EUR 25.5 million

- Outlook for 2017: Revenues between EUR 1.20 billion and EUR 1.23 billion,   EBITDA between EUR 85 million and EUR 105 million 

Bad Neustadt / Saale, 5th May 2017 

In the first quarter of the financial year 2017 a total of 212,187 patients were treated in the hospitals of RHÖN-KLINIKUM AG. Revenues for the same period amounted to EUR 300.1 million with earnings before interest, taxes, depreciation and amortization (EBITDA) standing at EUR 25.5 million. 

Annual General Meeting on 7^th June 2017

The Board of Management and Supervisory Board shall propose to this year's ordinary Annual General Meeting on 7th June 2017 in Frankfurt/Main the distribution of a dividend from the net consolidated profit in the amount of EUR 0.35 per non-par share. This results in a dividend amount of almost EUR 23.4 million based on the current number of roughly 67 million shares. 

Outlook

For the current financial year 2017 we expect revenues of between EUR 1.20 billion and EUR 1.23 billion. This is particularly adversely affected by the latest regulatory legislation, such as lower remuneration for special orthopaedic and cardiological services or the recently introduced discount for lower overheads in the area of additional services.

We expect EBITDA of between EUR 85 million and EUR 105 million for 2017. This includes negative effects in a low two-digit million figure for additional expenditure due to the digital transformation of medical processes and one-off burdens because of corporate restructuring. There is, however, also a positive effect from a possible dissolution of the structural financing shortfall at the university hospitals in Giessen and Marburg (UKGM) in the area of separate costing.

"Following the changes in the Board of Management which took place in the first quarter we are now concentrating on improving the profitability of the company as well as going ahead with our projects for the future," CEO Stephan Holzinger stated. "This is currently our campus concept linking in-patient and out-patient services more closely across various medical areas and also including downstream services, such as rehabilitation and care in the home. State-of-the-art digital technology and our WebEPA⁺ system for electronic patient records will be in use here. Our campus concept - ideally applied for the first time in our new hospital building in Bad Neustadt - is a completely new approach in providing forward-looking medical care in rural areas and also offers our company viable prospects for growth."

******************************************************************************

RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. At five medical sites with a total of about 5,400 beds we offer cutting-edge medical care with a direct link to universities and research institutes. Our top five key areas of treatment are cardiological and coronary disease, neurological disorders, oncology, lung diseases as well as orthopaedic and accident surgery. A total of approx. 16,500 employees work for RHÖN-KLINIKUM AG. Our facilities are located in Bad Berka, Bad Neustadt/Saale, Frankfurt (Oder) and Giessen and Marburg.

Further information is available at: www.rhoen-klinikum-ag.com.

Your Contact Persons:

RHÖN-KLINIKUM AG

Achim StruchholzGroup Division Head of Corporate CommunicationSchlossplatz 197616 Bad Neustadt / SaaleTelephone: + 49 - 9771 65-1327Facsimile: + 49 - 9771 65-1820E-Mail: kommunikation(at)rhoen-klinikum-ag.comDr. Kai G. KlingerGroup Division Head of Investor Relations & Group FinancingSchlossplatz 197616 Bad Neustadt / SaaleTelephone: + 49 - 9771 65-1318Facsimile: + 49 - 9771 99-1736E-Mail: ir(at)rhoen-klinikum-ag.com